Last reviewed · How we verify
MRX-I
At a glance
| Generic name | MRX-I |
|---|---|
| Sponsor | MicuRx |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants (PHASE1)
- MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (PHASE2)
- Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants (PHASE1)
- Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MRX-I CI brief — competitive landscape report
- MRX-I updates RSS · CI watch RSS
- MicuRx portfolio CI